BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29626476)

  • 1. Long non-coding RNA THOR promotes human osteosarcoma cell growth in vitro and in vivo.
    Chen W; Chen M; Xu Y; Chen X; Zhou P; Zhao X; Pang F; Liang W
    Biochem Biophys Res Commun; 2018 May; 499(4):913-919. PubMed ID: 29626476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling.
    Xue J; Zhong S; Sun BM; Sun QF; Hu LY; Pan SJ
    Cell Death Dis; 2019 Nov; 10(11):866. PubMed ID: 31727877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
    Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
    Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth.
    Jiao PF; Tang PJ; Chu D; Li YM; Xu WH; Ren GF
    Front Oncol; 2021; 11():756148. PubMed ID: 34868966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA THOR promotes human renal cell carcinoma cell growth.
    Ye XT; Huang H; Huang WP; Hu WL
    Biochem Biophys Res Commun; 2018 Jun; 501(3):661-667. PubMed ID: 29752937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
    Shang Y
    Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2BP1 over-expression in skin squamous cell carcinoma cells is essential for cell growth.
    Liu Z; Wu G; Lin C; Guo H; Xu J; Zhao T
    Biochem Biophys Res Commun; 2018 Jun; 501(3):731-738. PubMed ID: 29753746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA
    Wu H; He Y; Chen H; Liu Y; Wei B; Chen G; Lin H; Lin H
    FEBS Open Bio; 2019 Apr; 9(4):781-790. PubMed ID: 30984551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long non-coding RNA TP73-AS1 inhibits osteosarcoma cell proliferation and invasion through sponging miR-142.
    Yang G; Song R; Wang L; Wu X
    Biomed Pharmacother; 2018 Jul; 103():1238-1245. PubMed ID: 29864904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
    Zhang R; Xia T
    Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of long non-coding RNA HOST2 expression and its tumor-promotive function in human osteosarcoma.
    Qi XD; Xu SY; Song Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):921-927. PubMed ID: 29509239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Long Non-Coding RNA HOST2 On the Proliferation, Migration, Invasion and Apoptosis of Human Osteosarcoma Cells.
    Wang W; Li X; Meng FB; Wang ZX; Zhao RT; Yang CY
    Cell Physiol Biochem; 2017; 43(1):320-330. PubMed ID: 28854422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma.
    Zhang SZ; Cai L; Li B
    Bratisl Lek Listy; 2017; 118(10):632-636. PubMed ID: 29198132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lnc-MAP6-1:3 knockdown inhibits osteosarcoma progression by modulating Bax/Bcl-2 and Wnt/β-catenin pathways.
    Lin H; Wu T; Peng L; Su W; Wang Y; Li X; Liu Q; Zhong C; Huang J; Wei B
    Int J Med Sci; 2020; 17(15):2248-2256. PubMed ID: 32922188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA THOR promotes tongue squamous cell carcinomas by stabilizing IGF2BP1 downstream targets.
    Yang H; Fu G; Liu F; Hu C; Lin J; Tan Z; Fu Y; Ji F; Cao M
    Biochimie; 2019 Oct; 165():9-18. PubMed ID: 31220513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
    Li Y; Cai Q; Li W; Feng F; Yang L
    Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
    Wang Z; Liu Z; Wu S
    Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.